ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin

Goutelle, Sylvain*; Bourguignon, Laurent; Jelliffe, Roger W.; Conte, John E., Jr.; Maire, Pascal
Journal of Theoretical Biology2011-8-7DOI: 10.1016/j.jtbi.2011.05.013
22被引1阅读
引用收藏
分享

摘要

There is a critical need for improved and shorter tuberculosis (TB) treatment. Current in vitro models of TB, while valuable, are poor predictors of the antibacterial effect of drugs in vivo. Mathematical models may be useful to overcome the limitations of traditional approaches in TB research. The objective of this study was to set up a prototype mathematical model of TB treatment by rifampin, based on pharmacokinetic, pharmacodynamic and disease submodels. The full mathematical model can simulate the time-course of tuberculous disease from the first day of infection to the last day of therapy. Therapeutic simulations were performed with the full model to study the antibacterial effect of various dosage regimens of rifampin in lungs. The model reproduced some qualitative and quantitative properties of the bactericidal activity of rifampin observed in clinical data. The kill curves simulated with the model showed a typical biphasic decline in the number of extracellular bacteria consistent with observations in TB patients. Simulations performed with more simple pharmacokinetic/pharmacodynamic models indicated a possible role of a protected intracellular bacterial compartment in such a biphasic decline. This modeling effort strongly suggests that current dosage regimens of RIF may be further optimized. In addition, it suggests a new hypothesis for bacterial persistence during TB treatment.

学科与关键词

关键词
TuberculosisMathematical modelSimulationsPharmacokineticsPharmacodynamics
相关
加载中…
  • Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges
    Magombedze, Gesham; Pasipanodya, Jotam G.; Srivastava, Shashikant; Deshpande, Devyani; Visser, Marianne E.; Chigutsa, Emmanuel; McIlleron, Helen; Gumbo, Tawanda*Clinical Infectious Diseases, 2018, 67: S349-S358.被引 23
  • Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
    Srivastava, Shashikant; Deshpande, Devyani; Magombedze, Gesham; Gumbo, Tawanda*Clinical Infectious Diseases, 2018, 67: S359-S364.被引 16
  • Quantitative assessment of the activity of antituberculosis drugs and regimens
    Chirehwa, Maxwell T.*; Velasquez, Gustavo E.; Gumbo, Tawanda; McIlleron, HelenExpert Review of Anti-Infective Therapy, 2019, 17(6): 449-457.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Theoretical Biology
发表日期
2011-08-07
卷期
第 282 卷, 第 1 期
页码
80-92
DOI
10.1016/j.jtbi.2011.05.013
语言
MULTI-LANGUAGE
成果收录
SCIE

作者

  • G

    Goutelle, Sylvain (通讯) (第一作者)

  • B

    Bourguignon, Laurent

查看全部 5 位作者收起作者
  • J

    Jelliffe, Roger W.

  • C

    Conte, John E., Jr.

  • M

    Maire, Pascal

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417